Orthofix Intl NV (OFIX) Stock Price, Quote & News

Company Profile

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use...

Industry: Medical Devices

Sector: Healthcare

Phone: 214 937 2000

Website: orthofix.com

Address:

3451 Plano Parkway, Lewisville, United States

BillionerOfKing May. 11 at 5:48 PM

$OFIX Current Stock Price: $11.81 Contracts to trade: $12.5 OFIX May 15 2026 Call Entry: $2.05 Exit: $3.14 ROI: 53% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

mlanthoo May. 8 at 11:23 AM

$OFIX some insider buying

0 · Reply

StocktwitsEarnings May. 5 at 11:09 AM

$OFIX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.52 up 61.48% YoY • Reported revenue of $196.71M up 1.58% YoY • Orthofix targets an Adjusted EBITDA Margin of 11.50% for fiscal year 2026, increasing to 13.00% for 2027 and 15.00% for 2028. Orthofix also targets Revenue Growth of 7.00% for 2026, and 4.00% for 2027 and 2028.

0 · Reply

SuperGreenToday Apr. 17 at 8:19 PM

$OFIX Share Price: $12.72 Contract Selected: Nov 20, 2026 $17.5 Calls Buy Zone: $0.46 – $0.57 Target Zone: $0.75 – $0.91 Potential Upside: 53% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ANGRYmedINVESTOR Mar. 10 at 3:52 PM

$OFIX Dead company!

0 · Reply

d_risk Feb. 24 at 6:03 PM

$OFIX - Orthofix Medical Inc - 10K - Updated Risk Factors OFIX flags higher integration and synergy risk from its SeaSpine acquisition, rising pricing pressure from healthcare consolidation and powerful GPOs/IDNs, intensifying tech-driven competition that could render products obsolete, and expanded legal/regulatory exposure spanning internal controls, anti-bribery (FCPA), fraud/abuse laws, ACA-driven reimbursement uncertainty, and stricter global trade rules. #MedicalDevices #HealthcareConsolidation #RegulatoryCompliance #CompetitiveTechnology #IntegrationRisk 🟢 Added 🟠 Removed https://d-risk.ai/OFIX/10-K/2026-02-24

0 · Reply

StocktwitsEarnings Feb. 24 at 12:13 PM

$OFIX Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.06 up 92.00% YoY • Reported revenue of $219.91M up 1.97% YoY • Orthofix Medical Inc. estimates future amortization expense for intangible assets to be $15.18M in 2026, $14.79M in 2027, and $12.06M in 2028.

0 · Reply

SuperGreenToday Feb. 24 at 1:13 AM

$OFIX Share Price: $13.57 Contract Selected: Aug 21, 2026 $12.5 Calls Buy Zone: $0.59 – $0.73 Target Zone: $1.08 – $1.33 Potential Upside: 72% ROI Time to Expiration: 178 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

OfficialStocktwitsUser Feb. 21 at 9:38 PM

$OFIX RSI: 62.31, MACD: -0.1804 Vol: 0.31, MA20: 13.29, MA50: 14.41 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BillionerOfKing Feb. 20 at 2:52 AM

$OFIX Current Stock Price: $13.77 Contracts to trade: $15.0 OFIX Feb 20 2026 Call Entry: $0.90 Exit: $1.67 ROI: 85% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Orthofix announces FITBONE innovation at POSNA 2026 meeting

May 6, 2026, 7:00 AM EDT - 7 days ago

Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting

May 5, 2026, 3:47 PM EDT - 7 days ago

Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights

May 5, 2026, 8:30 AM EDT - 8 days ago

Orthofix Medical Earnings Call Transcript: Q1 2026

May 5, 2026, 7:00 AM EDT - 8 days ago

Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

Apr 24, 2026, 3:56 PM EDT - 18 days ago

Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX

Apr 21, 2026, 7:00 AM EDT - 22 days ago

Orthofix to Report First Quarter 2026 Financial Results

2026-04-09T11:48:29.000Z - 4 weeks ago

Orthofix announces spine leadership realignment

Apr 9, 2026, 7:00 AM EDT - 4 weeks ago

Orthofix Realigns Spine Leadership to Strengthen Focus and Execution

2026-03-09T11:16:29.000Z - 2 months ago

Orthofix price target lowered to $18 from $22 at Stifel

Mar 3, 2026, 11:10 AM EST - 2 months ago

Orthofix Medical Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 10:30 AM EST - 2 months ago

Orthofix Medical Transcript: 2026 CG Musculoskeletal Conference

2026-02-26T14:11:21.000Z - 2 months ago

Orthofix price target lowered to $20 from $24 at Canaccord

2026-02-25T12:48:53.000Z - 2 months ago

Orthofix price target lowered to $17 from $18 at Barrington

Feb 24, 2026, 8:30 AM EST - 2 months ago

Orthofix Medical Earnings Call Transcript: Q4 2025

2026-02-24T12:40:27.000Z - 2 months ago

Orthofix reports Q4 EPS (6c) vs. (75c) last year

2026-02-24T12:40:17.000Z - 2 months ago

Orthofix reports Q4 EPS (6c) vs. (75c) last year

Feb 24, 2026, 7:00 AM EST - 2 months ago

Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

Feb 10, 2026, 7:00 AM EST - 3 months ago

Orthofix to Participate in Upcoming Investor Conferences

Feb 3, 2026, 7:00 AM EST - 3 months ago

Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results

2026-01-26T21:45:26.000Z - 3 months ago

Orthofix initiated with a Hold at TD Cowen

Nov 12, 2025, 10:00 AM EST - 6 months ago

Orthofix Medical Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 1:15 PM EST - 6 months ago

Orthofix Medical Transcript: UBS Global Healthcare Conference 2025

2025-11-05T14:26:29.000Z - 6 months ago

Orthofix price target raised to $18 from $17 at Barrington

Nov 4, 2025, 8:30 AM EST - 6 months ago

Orthofix Medical Earnings Call Transcript: Q3 2025

2025-11-04T12:37:46.000Z - 6 months ago

Orthofix reports Q3 EPS (57c) vs. (71c) last year

Nov 4, 2025, 7:00 AM EST - 6 months ago

Orthofix Reports Third Quarter 2025 Financial Results

2025-10-28T10:55:26.000Z - 7 months ago

Orthofix resumed with a Buy at Stifel

Oct 14, 2025, 7:00 AM EDT - 7 months ago

Orthofix to Report Third Quarter 2025 Financial Results

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Orthofix Medical Earnings Call Transcript: Q2 2025

Aug 5, 2025, 7:00 AM EDT - 10 months ago

Orthofix Reports Second Quarter 2025 Financial Results

Jul 16, 2025, 7:00 AM EDT - 10 months ago

Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference

Jul 15, 2025, 7:00 AM EDT - 10 months ago

Orthofix to Report Second Quarter 2025 Financial Results

Jun 17, 2025, 7:00 AM EDT - 11 months ago

Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System

May 6, 2025, 8:30 AM EDT - 1 year ago

Orthofix Medical Earnings Call Transcript: Q1 2025

May 6, 2025, 7:00 AM EDT - 1 year ago

Orthofix Reports First Quarter 2025 Financial Results

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Orthofix Announces Appointment of Vickie Capps to Board of Directors

Mar 10, 2025, 12:00 PM EDT - 1 year ago

Orthofix Medical Transcript: CG 2025 Musculoskeletal Conference

Mar 3, 2025, 7:00 AM EST - 1 year ago

Orthofix to Participate in the 37th Annual Roth Conference

Feb 25, 2025, 8:30 AM EST - 1 year ago

Orthofix Medical Earnings Call Transcript: Q4 2024

Feb 25, 2025, 7:00 AM EST - 1 year ago

Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance

Feb 17, 2025, 7:05 AM EST - 1 year ago

Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Jan 28, 2025, 7:00 AM EST - 1 year ago

Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results

Nov 18, 2024, 8:35 AM EST - 1 year ago

Orthofix Medical Transcript: Stifel 2024 Healthcare Conference

Nov 7, 2024, 8:30 AM EST - 1 year ago

Orthofix Medical Earnings Call Transcript: Q3 2024

Nov 7, 2024, 7:05 AM EST - 1 year ago

Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets

Nov 7, 2024, 7:05 AM EST - 1 year ago

Orthofix Announces New Term Loan

Oct 21, 2024, 7:00 AM EDT - 1 year ago

Orthofix to Participate in Stifel 2024 Healthcare Conference

Oct 16, 2024, 10:39 AM EDT - 1 year ago

DEADLINE NEXT WEEK: Berger Montague Advises Orthofix Medical (NASDAQ: OFIX) Investors to Contact the Firm Before October 21, 2024

Oct 10, 2024, 7:00 AM EDT - 1 year ago

Orthofix to Report Third Quarter 2024 Financial Results

BillionerOfKing May. 11 at 5:48 PM

0 · Reply

mlanthoo May. 8 at 11:23 AM

$OFIX some insider buying

0 · Reply

StocktwitsEarnings May. 5 at 11:09 AM

0 · Reply

SuperGreenToday Apr. 17 at 8:19 PM

0 · Reply

ANGRYmedINVESTOR Mar. 10 at 3:52 PM

$OFIX Dead company!

0 · Reply

d_risk Feb. 24 at 6:03 PM

0 · Reply

StocktwitsEarnings Feb. 24 at 12:13 PM

0 · Reply

SuperGreenToday Feb. 24 at 1:13 AM

0 · Reply

OfficialStocktwitsUser Feb. 21 at 9:38 PM

0 · Reply

BillionerOfKing Feb. 20 at 2:52 AM

0 · Reply

ANGRYmedINVESTOR Feb. 19 at 4:54 PM

$OFIX HOLY COW HOW IS THIS COMPANY STILL ALIVE LMAO

0 · Reply

MeganJennings155 Feb. 11 at 3:56 PM

$OFIX Orthofix Medical; spine and orthopedics medtech; merger integration, CEO transition; sales force execution, competitive market.

0 · Reply

BillionerOfKing Feb. 9 at 5:07 PM

$OFIX Current Stock Price: $12.78 Contracts to trade: $12.5 OFIX Feb 20 2026 Call Entry: $2.79 Exit: $5.00 ROI: 79% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

ANGRYmedINVESTOR Jan. 27 at 7:02 PM

$OFIX ANOTHER TERRIBLE MED DEVICE STORY LOL

0 · Reply

AuroraArc Dec. 27 at 12:01 PM

$OFIX Confidence will depend on whether guidance becomes dependable; balance‑sheet optionality should not erode — execution across cycles would support multiple expansion. Markets will follow data, not narratives.

0 · Reply

PublicGoodsP Dec. 26 at 3:20 PM

$OFIX Risk appetite is present but conditioned on validation. Operating rhythm should stabilize as learning cycles compress. Risk compresses once delivery patterns become predictable. Without validation, volatility will remain persistent.

0 · Reply

DingDong9 Dec. 18 at 4:49 PM

$OFIX high conviction bet going into 2026

0 · Reply

SuperGreenToday Dec. 5 at 11:18 PM

$OFIX Share Price: $15.91 Contract Selected: May 15, 2026 $15 Calls Buy Zone: $0.21 – $0.26 Target Zone: $0.40 – $0.49 Potential Upside: 78% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

NVDAMillionaire Nov. 18 at 12:11 PM

$OFIX Excellent article that nails exactly where OFIX stands right now. So if you want to update your OFIX knowledge or get acquainted with OFIX, this is a must read. https://beyondspx.com/quote/OFIX/analysis/orthofix-forges-ahead-with-focused-innovation-and-margin-expansion-nasdaq-ofix

0 · Reply

JarvisFlow Nov. 5 at 2:32 PM

Barrington Research has updated their rating for Orthofix Medical ( $OFIX ) to Outperform with a price target of 18.

0 · Reply

JarvisFlow Oct. 23 at 11:33 AM

Barrington Research updates rating for Orthofix Medical ( $OFIX ) to Outperform, target set at 17.

0 · Reply

Market Cap	468.48M
Revenue (ttm)	822.31M
Net Income (ttm)	-92.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-11.21%
Debt to Equity Ratio	0.51

Volume	354,700
Avg Vol	291,198
Day's Range	N/A - N/A
Shares Out	40.14M
Stochastic %K	64%
Beta	0.79
Analysts	Sell
Price Target	$17.25